Novel secretion system of recombinant Saccharomyces cerevisiae using an N-terminus residue of human IL-1β as secretion enhancer

Jeewon Lee, Seong Il Choi, Jun Sung Jang, Kiryong Jang, Jae Woong Moon, Cheon Soon Bae, Doo Suk Yang, Baik Lin Seong

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

An N-terminus sequence of human interleukin 1β (hIL-1β) was used as a fusion expression partner for the production of two recombinant therapeutic proteins, human granulocyte-colony stimulating factor (hG-CSF) and human growth hormone (hGH), using Saccharomyces cerevisiae as a host. The expression cassette comprised the leader sequence of killer toxin of Kluyveromyces lactis, the N-terminus 24 amino acids (Ser5-Ala28) of mature hIL-1β, the KEX2 dibasic endopeptidase cleavage site, and the target protein (hG-CSF or hGH). The gene expression was controlled by the inducible UAS(gal)/MF-α1 promoter. With the expression vector above, both recombinant proteins were well secreted into culture medium with high secretion efficiencies, and especially, the recombinant hGH was accumulated up to around 1.3 g/L in the culture broth. This is due presumably to the significant role of fused hIL-1β as secretion enhancer in the yeast secretory pathway. In our recent report, various immunoblotting analyses have shown that the presence of a core N-glycosylation resident in the hIL-1β fragment is likely to be of crucial importance in the high-level secretion of hG-CSF from the recombinant S. cerevisiae. When the N-glycosylation was completely blocked with the addition of tunicamycin to the culture, the secretion of hG-CSF and hGH was decreased to a negligible level although the other host-derived proteins were well secreted to the culture broth regardless of the presence of tunicamycin. The N-terminal sequencing of the purified hG-CSF verified that the hIL-1β fusion peptide was correctly removed by in vivo KEX2 protease upon the exit of fusion protein from Golgi complex. From the results presented in this article, it is strongly suggested that the N-terminus fusion of the hIL-1β peptide could be utilized as a potent secretion enhancer in the expression systems designed for the secretory production of other heterologous proteins from S. cerevisiae.

Original languageEnglish
Pages (from-to)884-890
Number of pages7
JournalBiotechnology Progress
Volume15
Issue number5
DOIs
Publication statusPublished - 1999 Sep 17
Externally publishedYes

Fingerprint

interleukin-1
Interleukin-1
Saccharomyces cerevisiae
secretion
granulocyte colony-stimulating factor
Granulocyte Colony-Stimulating Factor
human growth
Human Growth Hormone
somatotropin
tunicamycin
Tunicamycin
glycosylation
Glycosylation
Recombinant Proteins
proteinases
peptides
Saccharomyces cerevisiae Proteins
Kluyveromyces marxianus var. lactis
biopharmaceuticals
Endopeptidases

ASJC Scopus subject areas

  • Food Science
  • Biotechnology
  • Microbiology

Cite this

Novel secretion system of recombinant Saccharomyces cerevisiae using an N-terminus residue of human IL-1β as secretion enhancer. / Lee, Jeewon; Choi, Seong Il; Jang, Jun Sung; Jang, Kiryong; Moon, Jae Woong; Bae, Cheon Soon; Yang, Doo Suk; Seong, Baik Lin.

In: Biotechnology Progress, Vol. 15, No. 5, 17.09.1999, p. 884-890.

Research output: Contribution to journalArticle

Lee, Jeewon ; Choi, Seong Il ; Jang, Jun Sung ; Jang, Kiryong ; Moon, Jae Woong ; Bae, Cheon Soon ; Yang, Doo Suk ; Seong, Baik Lin. / Novel secretion system of recombinant Saccharomyces cerevisiae using an N-terminus residue of human IL-1β as secretion enhancer. In: Biotechnology Progress. 1999 ; Vol. 15, No. 5. pp. 884-890.
@article{ede02604cc254bccadfcf231951b1c0b,
title = "Novel secretion system of recombinant Saccharomyces cerevisiae using an N-terminus residue of human IL-1β as secretion enhancer",
abstract = "An N-terminus sequence of human interleukin 1β (hIL-1β) was used as a fusion expression partner for the production of two recombinant therapeutic proteins, human granulocyte-colony stimulating factor (hG-CSF) and human growth hormone (hGH), using Saccharomyces cerevisiae as a host. The expression cassette comprised the leader sequence of killer toxin of Kluyveromyces lactis, the N-terminus 24 amino acids (Ser5-Ala28) of mature hIL-1β, the KEX2 dibasic endopeptidase cleavage site, and the target protein (hG-CSF or hGH). The gene expression was controlled by the inducible UAS(gal)/MF-α1 promoter. With the expression vector above, both recombinant proteins were well secreted into culture medium with high secretion efficiencies, and especially, the recombinant hGH was accumulated up to around 1.3 g/L in the culture broth. This is due presumably to the significant role of fused hIL-1β as secretion enhancer in the yeast secretory pathway. In our recent report, various immunoblotting analyses have shown that the presence of a core N-glycosylation resident in the hIL-1β fragment is likely to be of crucial importance in the high-level secretion of hG-CSF from the recombinant S. cerevisiae. When the N-glycosylation was completely blocked with the addition of tunicamycin to the culture, the secretion of hG-CSF and hGH was decreased to a negligible level although the other host-derived proteins were well secreted to the culture broth regardless of the presence of tunicamycin. The N-terminal sequencing of the purified hG-CSF verified that the hIL-1β fusion peptide was correctly removed by in vivo KEX2 protease upon the exit of fusion protein from Golgi complex. From the results presented in this article, it is strongly suggested that the N-terminus fusion of the hIL-1β peptide could be utilized as a potent secretion enhancer in the expression systems designed for the secretory production of other heterologous proteins from S. cerevisiae.",
author = "Jeewon Lee and Choi, {Seong Il} and Jang, {Jun Sung} and Kiryong Jang and Moon, {Jae Woong} and Bae, {Cheon Soon} and Yang, {Doo Suk} and Seong, {Baik Lin}",
year = "1999",
month = "9",
day = "17",
doi = "10.1021/bp9900918",
language = "English",
volume = "15",
pages = "884--890",
journal = "Biotechnology Progress",
issn = "8756-7938",
publisher = "John Wiley and Sons Ltd",
number = "5",

}

TY - JOUR

T1 - Novel secretion system of recombinant Saccharomyces cerevisiae using an N-terminus residue of human IL-1β as secretion enhancer

AU - Lee, Jeewon

AU - Choi, Seong Il

AU - Jang, Jun Sung

AU - Jang, Kiryong

AU - Moon, Jae Woong

AU - Bae, Cheon Soon

AU - Yang, Doo Suk

AU - Seong, Baik Lin

PY - 1999/9/17

Y1 - 1999/9/17

N2 - An N-terminus sequence of human interleukin 1β (hIL-1β) was used as a fusion expression partner for the production of two recombinant therapeutic proteins, human granulocyte-colony stimulating factor (hG-CSF) and human growth hormone (hGH), using Saccharomyces cerevisiae as a host. The expression cassette comprised the leader sequence of killer toxin of Kluyveromyces lactis, the N-terminus 24 amino acids (Ser5-Ala28) of mature hIL-1β, the KEX2 dibasic endopeptidase cleavage site, and the target protein (hG-CSF or hGH). The gene expression was controlled by the inducible UAS(gal)/MF-α1 promoter. With the expression vector above, both recombinant proteins were well secreted into culture medium with high secretion efficiencies, and especially, the recombinant hGH was accumulated up to around 1.3 g/L in the culture broth. This is due presumably to the significant role of fused hIL-1β as secretion enhancer in the yeast secretory pathway. In our recent report, various immunoblotting analyses have shown that the presence of a core N-glycosylation resident in the hIL-1β fragment is likely to be of crucial importance in the high-level secretion of hG-CSF from the recombinant S. cerevisiae. When the N-glycosylation was completely blocked with the addition of tunicamycin to the culture, the secretion of hG-CSF and hGH was decreased to a negligible level although the other host-derived proteins were well secreted to the culture broth regardless of the presence of tunicamycin. The N-terminal sequencing of the purified hG-CSF verified that the hIL-1β fusion peptide was correctly removed by in vivo KEX2 protease upon the exit of fusion protein from Golgi complex. From the results presented in this article, it is strongly suggested that the N-terminus fusion of the hIL-1β peptide could be utilized as a potent secretion enhancer in the expression systems designed for the secretory production of other heterologous proteins from S. cerevisiae.

AB - An N-terminus sequence of human interleukin 1β (hIL-1β) was used as a fusion expression partner for the production of two recombinant therapeutic proteins, human granulocyte-colony stimulating factor (hG-CSF) and human growth hormone (hGH), using Saccharomyces cerevisiae as a host. The expression cassette comprised the leader sequence of killer toxin of Kluyveromyces lactis, the N-terminus 24 amino acids (Ser5-Ala28) of mature hIL-1β, the KEX2 dibasic endopeptidase cleavage site, and the target protein (hG-CSF or hGH). The gene expression was controlled by the inducible UAS(gal)/MF-α1 promoter. With the expression vector above, both recombinant proteins were well secreted into culture medium with high secretion efficiencies, and especially, the recombinant hGH was accumulated up to around 1.3 g/L in the culture broth. This is due presumably to the significant role of fused hIL-1β as secretion enhancer in the yeast secretory pathway. In our recent report, various immunoblotting analyses have shown that the presence of a core N-glycosylation resident in the hIL-1β fragment is likely to be of crucial importance in the high-level secretion of hG-CSF from the recombinant S. cerevisiae. When the N-glycosylation was completely blocked with the addition of tunicamycin to the culture, the secretion of hG-CSF and hGH was decreased to a negligible level although the other host-derived proteins were well secreted to the culture broth regardless of the presence of tunicamycin. The N-terminal sequencing of the purified hG-CSF verified that the hIL-1β fusion peptide was correctly removed by in vivo KEX2 protease upon the exit of fusion protein from Golgi complex. From the results presented in this article, it is strongly suggested that the N-terminus fusion of the hIL-1β peptide could be utilized as a potent secretion enhancer in the expression systems designed for the secretory production of other heterologous proteins from S. cerevisiae.

UR - http://www.scopus.com/inward/record.url?scp=0033198602&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033198602&partnerID=8YFLogxK

U2 - 10.1021/bp9900918

DO - 10.1021/bp9900918

M3 - Article

C2 - 10514258

AN - SCOPUS:0033198602

VL - 15

SP - 884

EP - 890

JO - Biotechnology Progress

JF - Biotechnology Progress

SN - 8756-7938

IS - 5

ER -